Ha Tay Pharmaceutical JSC (HNX:DHT)

Patterson Companies Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,076,681	2,086,353	1,999,304	1,837,395	1,609,364	2,006,475
Revenue Growth (YoY)	4.78%	4.35%	8.81%	14.17%	-19.79%	-1.75%
Cost of Revenue	1,849,502	1,866,534	1,795,972	1,650,138	1,455,342	1,767,422
Gross Profit	227,179	219,818	203,331	187,256	154,022	239,053
Selling, General & Admin	148,724	143,306	104,115	84,806	91,953	129,633
Operating Expenses	148,724	143,306	104,115	84,806	91,953	129,633
Operating Income	78,455	76,513	99,216	102,450	62,070	109,420
Interest Expense	-13,509	-13,449	-20,099	-14,304	-13,993	-13,323
Interest & Investment Income	24,778	19,544	19,614	25,120	30,725	14,355
Earnings From Equity Investments	8,182	6,756	4,171	2,971	1,996	1,363
Currency Exchange Gain (Loss)	1,063	-	-	-	-	-
Other Non Operating Income (Expenses)	5,749	5,858	7,442	6,986	8,715	8,721
EBT Excluding Unusual Items	104,717	95,222	110,344	123,224	89,513	120,536
Pretax Income	104,717	95,222	110,344	123,224	89,513	120,536
Income Tax Expense	21,765	20,028	21,382	24,259	18,123	24,427
Earnings From Continuing Operations	82,953	75,194	88,961	98,964	71,390	96,109
Minority Interest in Earnings	-4,524	-3,422	-3,906	-3,753	-3,444	-4,061
Net Income	78,429	71,772	85,056	95,211	67,946	92,047
Net Income to Common	78,429	71,772	85,056	95,211	67,946	92,047
Net Income Growth	6.08%	-15.62%	-10.67%	40.13%	-26.18%	6.74%
Shares Outstanding (Basic)	82	82	51	-	-	-
Shares Outstanding (Diluted)	82	82	51	-	-	-
Shares Change (YoY)	-	62.83%	-	-	-	-
EPS (Basic)	952.50	871.65	1681.99	-	-	-
EPS (Diluted)	952.50	871.65	1681.99	-	-	-
EPS Growth	-	-48.18%	-	-	-	-
Free Cash Flow	-61,774	-115,173	-95,725	-286,024	-83,817	5,466
Free Cash Flow Per Share	-750.23	-1398.74	-1892.97	-	-	-
Dividend Per Share	-	-	-	-	357.143	-
Gross Margin	10.94%	10.54%	10.17%	10.19%	9.57%	11.91%
Operating Margin	3.78%	3.67%	4.96%	5.58%	3.86%	5.45%
Profit Margin	3.78%	3.44%	4.25%	5.18%	4.22%	4.59%
Free Cash Flow Margin	-2.97%	-5.52%	-4.79%	-15.57%	-5.21%	0.27%
EBITDA	100,007	96,993	116,294	119,898	78,721	122,680
EBITDA Margin	4.82%	4.65%	5.82%	6.53%	4.89%	6.11%
D&A For EBITDA	21,552	20,481	17,078	17,448	16,651	13,259
EBIT	78,455	76,513	99,216	102,450	62,070	109,420
EBIT Margin	3.78%	3.67%	4.96%	5.58%	3.86%	5.45%
Effective Tax Rate	20.78%	21.03%	19.38%	19.69%	20.25%	20.27%
Revenue as Reported	2,076,681	2,086,353	1,999,304	1,837,395	1,609,364	2,006,475

Source: S&P Global Market Intelligence. Standard template. Financial Sources.